Go back

DH (NICE): licensed, unlicensed and off-label medicines

The Department of Health’s National Institute for Health and Clinical Excellence invites tenders for an evaluation of licensed, unlicensed and off-label medicines.

Funding is available for a high-quality service that summarises the best available evidence for selected unlicensed and off-label medicines where a demand for information has been identified for use in the NHS in England.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.